Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2023
Reporting Period: Third quarter ended September 30, 2023
This filing serves as a notification that the Company issued a press release and held a conference call on November 10, 2023, to announce its financial results for the third quarter of 2023. The detailed financial data is contained in the attached press release (Exhibit 99.1) and is not embedded directly within the text of this Form 8-K.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the press release dated November 10, 2023, and on the Company's investor website.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the announcement of the third-quarter results.
Guidance, Outlook, and Risks
Management Commentary: The Company conducted a business update via conference call on November 10, 2023, at 8:30 am EST. Materials related to this update are available at www.sanuwave.com/investors.
Legal Disclaimer: The information in Item 2.02 and the attached exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q3 2023 financial figures.
- Access the investor relations website (www.sanuwave.com/investors) for the conference call materials and business update.
- Verify the Company's status as an emerging growth company (indicated as checked in the filing).
- Note that the registrant has no securities registered under Section 12(b) of the Act (Trading Symbol and Exchange listed as N/A).